The final, formatted version of the article will be published soon.
SYSTEMATIC REVIEW article
Front. Oral. Health
Sec. Oral Cancers
Volume 5 - 2024 |
doi: 10.3389/froh.2024.1524313
This article is part of the Research Topic Immuno-Oncologic Biomarker Signatures for Personalized Immunotherapy and Immunoprevention in Oral Squamous Cell Carcinoma View all 4 articles
The Prognostic Significance of Tertiary Lymphoid Structures in Oral Squamous Cell Carcinomas: A Systematic Review
Provisionally accepted- 1 Assistance Publique Hopitaux De Paris, Paris, France
- 2 Université Paris-Cité, Faculté de Santé, UFR Odontologie, Paris, France
- 3 INSERM U1135 Centre d'Immunologie et de Maladies Infectieuses, Paris, Île-de-France, France
- 4 Faculté de Santé Sorbonne Université, Sorbonne Université, UMRS 1135, Paris, France
- 5 Laboratory “Immune microenvironment and immunotherapy”, Centre d’Immunologie et des Maladies Infectieuses Paris (CIMI-Paris), Paris, France
- 6 Service Odontologie, Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Paris, France
Upper aerodigestive tract cancers are prevalent, with a global incidence surpassing 500,000 new cases in 2018. Among these, oral squamous cell carcinomas (OSCC) constitute the majority. OSCC has a low 5-year survival rate due to late-stage diagnosis. Risk factors include alcohol and tobacco use.However, non-smokers and non-drinkers are also affected, especially young patients with tongue cancer. The impact of tumor microenvironment (TME) and tumor-infiltrating lymphocytes (TILs) on OSCC prognosis remains debated. Remarkably, Tertiary Lymphoid Structures (TLS) identified in solid tumors have shown associations with favorable outcomes, yet their prognostic significance in OSCC remains understudied. Thus, this systematic review aims to explore the value of TLS in OSCC reported in the literature. A scoping review was conducted and six retrospective cohort studies involving 1,203 patients met the inclusion criteria. Predominantly male patients, with an average age of 49.3 years were included. Immunohistochemistry was the primary method to identify TLS, present in 21% up to 100% of cases. TLS were predominantly located in the peri-tumoral area (75.4-84.8%) compared to the intratumoral area (33.8-33.9%). Our review shows that the presence of TLS is associated with improved survival in OSCC. However, variations in TLS detection and classification methods across studies introduce potential biases, hindering direct comparisons between findings. For instance, reports that are based solely on examining HES-stained slides for TLS identification may raise reliability concerns.Standardization of methodologies is imperative to ensure consistency in criteria utilization, thereby facilitating meaningful data comparisons.
Keywords: oral cancer, Oral Oncoimmunology, oral squamous cell carcinoma, prognostic biomarker, tertiary lymphoid structures
Received: 07 Nov 2024; Accepted: 31 Dec 2024.
Copyright: © 2024 Ribeiro, Teillaud, Dieu-Nosjean, Lescaille and Rochefort. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Vianney Ribeiro, Assistance Publique Hopitaux De Paris, Paris, France
Juliette Rochefort, Faculté de Santé Sorbonne Université, Sorbonne Université, UMRS 1135, Paris, France
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.